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Sleep is a restorative circadian process underpinned by numerous interrelated biological processes
(Brown et al., 2012; Goel et al., 2013; Zeitzer, 2013; Vyazovskiy and Delogu, 2014). Specifically,
biological rhythms in core temperature, blood pressure, immune function as well as melatonin,
and other hormones demonstrate an intricate relationship with sleep (Zisapel, 2007). Therefore,
whilst sufficient sleep [7–9 h is recommended by the National Sleep Foundation (NSF) for adults
(Hirshkowitz et al., 2015)] facilitates an optimal internal temporal order, an increased risk of poor
quality of life, morbidity, and mortality (Zisapel, 2007) are seen with insufficient sleep (<6 h is not
recommended by the NSF for adults), which is currently a concern in both the general population
and athletes (Halson, 2015).
Recent reviews (Fullagar et al., 2015a,b; Nédélec et al., 2015a; Thun et al., 2015) outline the
proposed importance of sleep for athletes to reduce illness and injury rates (Luke et al., 2011;
Milewski et al., 2014) whilst optimizing recovery and/or subsequent athletic performance (see
Fullagar et al., 2015b for definition of terms). Moreover, the need for sufficient sleep to promote
general mental and physical development within adolescent athletes has recently been highlighted
by the International Olympic Committee (Bergeron et al., 2015). Practitioners and clinicians are
thus under increasing pressure to encourage sufficient sleep in their athletes, since inadequate sleep
has been reported to reduce various physical performance measures (Bulbulian et al., 1996; Souissi
et al., 2003; Blumert et al., 2007; Oliver et al., 2009; Skein et al., 2013; Smith et al., 2013; Fullagar
et al., 2015a; Thun et al., 2015). However, a dose response relationship between sleep loss and
performance decrement has not been well established.
Limited evidence is available regarding the negative influence of circadian desynchrony (Smith
et al., 2013), sleep disturbance (Souissi et al., 2013), and sleep deprivation (Skein et al., 2013)
on athletic performance (see recent reviews Fullagar et al., 2015a,b). However, pharmacologically
mediated improvements in sleep quality in the presence, or not, of these challenges is sparse
within healthy athletic populations, as are data regarding any pharmacologically mediated athletic
performance “hangover” effects within or next day (as discussed later in the present opinion
article). Despite this limited evidence anecdotal reports from the media and those involved
within professional sport suggest increased pressure on the medical practitioner to prescribe sleep
medications. This pressure can be exerted from team managers, coaches and from the athletes
themselves. Evidently there is likely disconnect between evidence and current practice.
Professional sportspeople (both players and officials) face unique challenges relative to their
ability to achieve sufficient sleep (Sargent et al., 2014; Bergeron et al., 2015; Fullagar et al., 2015b;
Juliff et al., 2015; Lastella et al., 2015a,b; Nédélec et al., 2015a; Thun et al., 2015). For example,
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inter- and intra-continental travel is common (McGuckin
et al., 2014), with athletic performance often proximal to both
departure and return travel (Reilly et al., 2005; Richmond
et al., 2007; Pipe, 2011; Schwellnus et al., 2012). Alternating
training and competition timings can be experienced by athletes,
with morning, afternoon, and evening competition and training
(Eagles et al., 2014; Meyer et al., 2014; Fullagar et al., 2016) often
evident in a non-cyclical manner across a season (Fullagar et al.,
2015b). On- and off-field competition demands can also impact
sleep, especially during fixture congestion and ultra-competitive
periods of the season (Murray et al., 2014; Carling et al., 2015;
Dellal et al., 2015; Juliff et al., 2015), which are compounded
by everyday life and family demands. Interestingly, individual
athletes were shown to retire and wake earlier whilst obtaining
less sleep (∼ –0.5 h) than athletes from team sports (Lastella
et al., 2015b). Whilst the night prior to (∼ –0.9 h) and on the first
evening of competition (∼ –0.6 h) cyclists achieved less sleep than
compared to pre-competition baseline values (∼ 7.4 h; Lastella
et al., 2015a). Such data (Lastella et al., 2015a,b) reinforces
the need for individualized sleep maintenance/enhancement
strategies within and between athletic disciplines (Fullagar and
Bartlett, 2015) whilst indicating why sleep medications are
utilized prior to and within competition phases. Some religions
also face unique challenges, for example during Ramadan,
training, nutritional, and prayer demands interact to negatively
influence sleep (Roky et al., 2001; Reilly and Waterhouse, 2007;
Zerguini et al., 2007; BaHammam et al., 2010; Chamari et al.,
2016). Empirical data demonstrates Ramadan fasting reduces
sleep duration [with (∼ –1.13 h) and without napping (∼ –1.29
h)] whilst delaying bedtime by ∼1.32 h, when compared to non-
fasting base-line control values (BaHammam et al., 2013). Indeed,
Ramadan fasting was recently shown to double night awakenings
(∼2 vs. 4), increase light sleep (∼2.5 h vs. ∼1 h), reduce deep
(∼1.5 h vs. ∼0.5 h), and rapid eye movement (∼1.5 h vs. ∼0.6 h)
sleep, compared to baseline control values, respectively, within
trained cyclists (Chamari et al., 2016). Therefore, achieving
sufficient sleep for consecutive days is evidently challenging for
athletes across the globe.
To address this challenge, three main intervention types
have been explored/prescribed by sports medicine/science
practitioners; pharmacological (Reilly et al., 2001), nutritional
(Halson, 2008, 2014; Costello et al., 2014), and sleep hygiene
(Fowler et al., 2015; Nédélec et al., 2015b). Pharmacological
interventions are utilized despite the paucity of evidence
regarding their efficacy relative to sleep within healthy
populations (Paul et al., 2001, 2003, 2004a,b). In addition,
much of the data has limited external validity to practice for
a multitude of reasons, including the participant population
(e.g., insomniacs, Buscemi et al., 2007; Vandermeer et al., 2007;
Sullivan, 2012; Zisapel, 2012; Riemann et al., 2015; rather than
healthy individuals and/or athletes) and outcome measures used
(i.e., lack of familiarization, no placebo, and/or true control
condition and lack of sport specific performance tests). Of
further concern is recent anecdotal evidence suggesting that
sleep medication overreliance/abuse is frequent in elite athletes,
including off-prescription non-physician approved use and/or
physician prescribed approved use. Therefore, this opinion
article seeks to discuss specific future research directions related
to the sleep medication that practitioners and athletes are
currently utilizing, particularly how the current literature lacks
external validity for sport medicine/science practitioners. It aims
to suggest data which researchers could develop in the future
to underpin their practice, relative to sleep medication use and
subsequent within or next day athletic performance.
The incidence of prescribed and over-the-counter sleep
medication use within professional sport remains to be reported
upon, though data from collegiate athletes indicates sport-
specific differences. A 2014 report from the National Collegiate
Athletic Association (NCAA) indicated that male and female
swimmers had the highest incidence of sleepmedication use (18.2
and 16.9%, respectively) compared to any other sport assessed,
with such medication accounting for 10.3% of miscellaneous
substance use across all sports (Rexroat, 2014). Recreational
sleep medication [n.b. sleep medications are not presently on
the 2016 World Anti-Doping Agency (WADA) list] use in
conjunction with energy drinks and/or alcohol to produce a
chemical “high,” akin to the effects of some recreationally abused
drugs (which are evidentlyWADA prohibited) has been reported
within elite athletes, and is evidently of concern to practitioners.
Indeed, Olympic champions have openly been placed into
drug rehabilitation due to dependence on sleep medication,
with a high profile Olympic nation recently banning all sleep
medication use by their athletes once selected for Rio 2016;
advancing their previous ban for certain hypnotic medications
employed only 3 weeks prior to London 2012.
The concept of “appropriate” sleep medication use by
athletes and practitioners is typically categorized under three
circumstances; (i) pre/post competition or post training to reduce
arousal (sedative action), (ii) to combat jet-lag (chronobiological
purpose), and (iii) for habitually poor sleepers (manage
insomnia). Sports medicine/science practitioners and their
athletes have various classes of sleep medication to rely upon.
Those drugs requiring a prescription and used on-label are ligand
γ-aminobutyric acid (GABA) agonists or receptor modulators,
benzodiazepine hypnotics (for simplicity z-drugs are included
within this class), melatonin receptor agonists (principally
Circardin R©) and off-label use of sedative anti-depressants.
Over-the-counter sleep medications are typically antihistamine
based, with some off-label use of allergy specific drugs seen.
Pharmacological review of each of these medications is beyond
the scope of this opinion piece, instead, practitioners are directed
to recent reviews for this information (Buscemi et al., 2007;
Vandermeer et al., 2007; Sullivan, 2012; Zisapel, 2012; Costello
et al., 2014).
Within healthy volunteers (i.e., those without clinically
diagnosed insomnia) the next day (or upon awakening) effects
of various sleep medications on psychomotor performance have
been reported (Paul et al., 2003, 2004a,b). However, within
athletic populations, intermittent high-intensity, prolonged
endurance, and resistance based exercise, post ingestion of
sleep medications, has not been extensively explored without
the presence of confounding factors. Ecologically, the residual
effects of such medication administered the evening before
competition/training and their influence on subsequent athletic
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performance (i.e., the next day) is relatively unknown. For
example, the efficacy of these medications to positively influence
sleep duration, efficiency, latency, and inertia, together with
perceived sleep quality, is limited within apparently healthy
and/or athletic (particularly elite) populations. Instead data is
often ascertained from clinically diagnosed sufferers of insomnia
(Buscemi et al., 2007; Vandermeer et al., 2007; Sullivan, 2012;
Zisapel, 2012; Riemann et al., 2015) and/or from non-athletic
but apparently healthy populations (Paul et al., 2001, 2003,
2004a,b); thus a disconnect between evidence and practice is
seen. Within (1.25 and 5.25 h post-ingestion; Atkinson et al.,
2005) and next day (∼9 h post-ingestion; Atkinson et al., 2001),
negligible improvements were reported in physical performance
(4 km cycling time trial and grip strength) following melatonin
(5mg) ingestion within physically active males. However, there
were notable decrements in alertness, reaction time and short-
term memory recall, despite no improvement in subjective sleep
quality when melatonin was ingested 30min before bed time.
Other related experimental designs (efficacy of sleep medication
upon sleep quality and any performance “hangover” effects)
utilizing eight male University volleyball team players have been
reported, though a lack of robust familiarization across the
physical and cognitive tests employed and the non-elite status
of the participants, preclude data inferences from secure use
by practitioners (Ito et al., 2007). Lastly, similar examples of
exercise performance post-sleep medication ingestion have been
conducted at altitude, yet these do not utilize robust familiarized,
reliable, and externally valid assessments of physical performance
and evidently the confounding influence of sojourn to various
altitude elevations is present (Beaumont et al., 2004; Nickol et al.,
2006; Jouanin et al., 2009).
Simple placebo, double-blind experimental designs, with a
true control condition, exploring sleep medication use and its
influence on familiarized and reliable subsequent (or within)
day athletic performance (i.e., influence of sleep medication
on performance trials compared to pre-medication baseline;
Fullagar et al., 2015b) are therefore required for practitioners
to base their practice upon. Moreover, specific emphasis on
athletic populations (ideally elite athletes) within appropriate
age boundaries, at sea-level and without chronobiological
disturbances is warranted. It is only once this basic evidence
is compiled that more complex designs can be adopted.
Evidently, there are a plethora of different sleep medications
(see recent reviews Buscemi et al., 2007; Vandermeer et al.,
2007; Sullivan, 2012; Zisapel, 2012; Costello et al., 2014),
complicated by brand names and their variation within and
between countries. Hence, practitioners should be directed by
medically qualified staff with sufficient expertise relative to
such medication. Researchers exploring this paradigm should
also collaborate with medically qualified support staff, athletes
and relevant practitioners, discussing the efficacy and external
validity of medication options, with attention to potency,
half-life and dosage key to maximizing external validity and
reducing next (or within) day performance decrement risk.
The use of such medication would evidently have to be
flexible regarding the drug of choice, given the changing
training and competition demands across a season (e.g.,
an English Premier League soccer season, with competing
UEFA Champions League demands), chronotype variation
(Waterhouse et al., 2002; Facer-Childs and Brandstaetter, 2015),
and individual responses to different drugs and dosages (Evans
and Johnson, 2001; Zhang and Dolan, 2010; Rissmann et al.,
2012). Greater evidence for practitioners, enhanced interaction
between medically qualified staff, athletes and practitioners,
and tri-partite education within this axis, would hopefully
reduce self-administration and off-label use of such medications
by athletes, especially given the affinity for some of these
medications to induce dependency in a matter of weeks and
the reported “recreational” use of these drugs by some elite
athletes.
Relative to this call for data, it is important that aside
from residual performance decrements, the general and future
health of athletes is of concern to practitioners. Some of these
medications can induce dependency in a matter of weeks, and
other health concerns within the clinical literature (though
typically related to older members of society) are suggestive
of an increased cancer risk (Kripke et al., 2012), accidental
over-dose, and dangerous drug interactions particularly when
opioid based analgesia is in use (Park et al., 2015). Lastly, some
unexpected risks for athletes, and the general public, regarding
sleep medication use are also present, e.g., new use of sedative
hypnotics is associated with an increased risk of a motor vehicle
crash (Hansen et al., 2015).
Therefore, to summarize the authors believe that the following
research questions should be explored, in order to provide
evidence for practitioners to (a) utilize within their practice and
(b) stimulate further more complex research designs:
(i) Current sleep medication (and other sleep interventions)
use within elite sport, similar to the NCAA data discussed
(Rexroat, 2014).
(ii) Sleep medication use within athletic populations (ideally
elite athletes) and their impact upon sleep duration,
efficiency, latency and inertia together with perceived sleep
quality, with efficacy assessed by polysomnography within
a laboratory environment and actigraphy within applied
settings (Leeder et al., 2012).
(iii) Sleep medication use within athletic populations (ideally
elite) and their impact upon intermittent high-intensity,
prolonged endurance and resistance based exercise
(perceptual and performance orientated outcome
measures), and cognitive function, within and next
day.
(iv) The efficacy of sleep hygiene and non-pharmacological sleep
enhancing interventions (Halson, 2008, 2014; Fowler et al.,
2015; Nédélec et al., 2015b) relative to the data generated in
response to (ii) and (iii).
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